HIGHLIGHTS
- who: Huohuan Tian and collaborators from the National Hospital Organization Kyoto Medical Center, Japan University, China have published the research work: Case report: Identification of acute promyelocytic leukemia during osimertinib resistance followed by granulocyte colony-stimulating factor and pembrolizumab, in the Journal: (JOURNAL) of 30/04/2022
- what: The authors report a case of t-APL with advanced non-small cell lung cancer (NSCLC) after targeted therapy and IMRT followed by granulocyte colony-stimulating factor (G-CSF) and immune checkpoint inhibitor (ICI) treatment.
SUMMARY
Therapy-related acute myeloid leukemia (t-AML . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.